🟢 Beam Therapeutics is trading 4.4% up today on broader risk-on sentiment and easing macro tensions

Beam Therapeutics is trading at $26.20 (4.4%) up today, rebounding from last week's biotech sector weakness as broader market sentiment improves.

• The stock is rising alongside major indices and risk assets, driven by easing oil prices and cooling macro tensions.
• There are no fresh company-specific catalysts; the move follows a period of consolidation since the July 24 update regarding upcoming BEAM-302 data.